Fluorescein Sodium and Benoximate Hydrocholoride Ophthalmic Solution USP

DRUG2 trials

Sponsors

Bausch & Lomb Incorporated

Conditions

Hyperemia

Phase 3

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

CompletedNCT01959243

Bausch & Lomb IncorporatedHyperemia

Start: 2014-02-22End: 2014-06-23Updated: 2019-10-23

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

CompletedNCT01959230

Bausch & Lomb IncorporatedHyperemia

Start: 2013-11-07End: 2013-12-20Updated: 2019-10-23